KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Dividends Paid - Common (2017 - 2020)

Historic Dividends Paid - Common for Biogen (BIIB) over the last 7 years, with Q4 2020 value amounting to $100000.0.

  • Biogen's Dividends Paid - Common fell 9767.44% to $100000.0 in Q4 2020 from the same period last year, while for Sep 2021 it was $75.3 million, marking a year-over-year increase of 80.32%. This contributed to the annual value of $71.0 million for FY2020, which is N/A changed from last year.
  • Per Biogen's latest filing, its Dividends Paid - Common stood at $100000.0 for Q4 2020, which was down 9767.44% from $70.9 million recorded in Q3 2020.
  • Biogen's Dividends Paid - Common's 5-year high stood at $302.7 million during Q1 2017, with a 5-year trough of -$2.0 million in Q3 2018.
  • For the 4-year period, Biogen's Dividends Paid - Common averaged around $59.2 million, with its median value being $4.3 million (2019).
  • Per our database at Business Quant, Biogen's Dividends Paid - Common skyrocketed by 96000.0% in 2019 and then plummeted by 9767.44% in 2020.
  • Biogen's Dividends Paid - Common (Quarter) stood at $302.7 million in 2017, then tumbled by 100.17% to -$500000.0 in 2018, then skyrocketed by 960.0% to $4.3 million in 2019, then plummeted by 97.67% to $100000.0 in 2020.
  • Its last three reported values are $100000.0 in Q4 2020, $70.9 million for Q3 2020, and $4.3 million during Q4 2019.